Kemwell to double European capacity

India-based contract manufacturer Kemwell is nearly doubling its space at a facility in Uppsala, Sweden. Construction is on a fast track: The company says production in the new facility will begin this year.

The building is a 16,000-square-meter former Pfizer plant, from which Kemwell launched its European business four years ago. The CMO is boosting its operations space to 31,000 square meters to keep pace with growth.

It will use the additional space to increase production of the tablets, suppositories and capsules that are its mainstays, as well as readying the manufacturer to expand into other product types. New formulations also are in the plans, as is expansion of contractor's analytical and method development service offerings and stability studies.

- see this article


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.